159 related articles for article (PubMed ID: 30362332)
21. Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer.
Veena MS; Raychaudhuri S; Basak SK; Venkatesan N; Kumar P; Biswas R; Chakrabarti R; Lu J; Su T; Gallagher-Jones M; Morselli M; Fu H; Pellegrini M; Goldstein T; Aladjem MI; Rettig MB; Wilczynski SP; Shin DS; Srivatsan ES
J Biol Chem; 2020 Dec; 295(50):17169-17186. PubMed ID: 33028635
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival.
Bhatt K; Zhou L; Mi QS; Huang S; She JX; Dong Z
Mol Med; 2010; 16(9-10):409-16. PubMed ID: 20386864
[TBL] [Abstract][Full Text] [Related]
23. CRISPR-mediated knockdown of miR-214 modulates cell fate in response to anti-cancer drugs in HPV-negative and HPVpositive cervical cancer cells.
Sen P; Ghosal S; Hazra R; Mohanty R; Arega S; Sahu B; Ganguly N
J Biosci; 2020; 45():. PubMed ID: 32554905
[TBL] [Abstract][Full Text] [Related]
24. Synergistic anticancer activity of 5-aminolevulinic acid photodynamic therapy in combination with low-dose cisplatin on Hela cells.
Wei XQ; Ma HQ; Liu AH; Zhang YZ
Asian Pac J Cancer Prev; 2013; 14(5):3023-8. PubMed ID: 23803073
[TBL] [Abstract][Full Text] [Related]
25. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis.
Shao X; Zheng X; Ma D; Liu Y; Liu G
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 33645623
[TBL] [Abstract][Full Text] [Related]
27. microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status.
Wang X; Dong K; Gao P; Long M; Lin F; Weng Y; Ouyang Y; Ren J; Zhang H
Cancer Biother Radiopharm; 2013 Feb; 28(1):45-50. PubMed ID: 23036084
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer.
Chi RA; van der Watt P; Wei W; Birrer MJ; Leaner VD
BMC Cancer; 2021 Feb; 21(1):106. PubMed ID: 33530952
[TBL] [Abstract][Full Text] [Related]
29. HP1γ Sensitizes Cervical Cancer Cells to Cisplatin through the Suppression of UBE2L3.
Yi SA; Kim GW; Yoo J; Han JW; Kwon SH
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825184
[TBL] [Abstract][Full Text] [Related]
30. Chloroquine synergizes doxorubicin efficacy in cervical cancer cells through flux impairment and down regulation of proteins involved in the fusion of autophagosomes to lysosomes.
Bano N; Ansari MI; Kainat KM; Singh VK; Sharma PK
Biochem Biophys Res Commun; 2023 May; 656():131-138. PubMed ID: 36963349
[TBL] [Abstract][Full Text] [Related]
31. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells.
Yu G; Zhong N; Chen G; Huang B; Wu S
Tumour Biol; 2014 Oct; 35(10):10341-9. PubMed ID: 25038915
[TBL] [Abstract][Full Text] [Related]
33. 5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis.
Hu Z; Fan H; Lv G; Zhou Q; Yang B; Zheng J; Cao W
J Dermatol Sci; 2015 Aug; 79(2):155-62. PubMed ID: 25982144
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
[TBL] [Abstract][Full Text] [Related]
35. Vitamin C in synergism with cisplatin induces cell death in cervical cancer cells through altered redox cycling and p53 upregulation.
Leekha A; Gurjar BS; Tyagi A; Rizvi MA; Verma AK
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2503-2514. PubMed ID: 27613187
[TBL] [Abstract][Full Text] [Related]
36. miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.
Nakatani F; Ferracin M; Manara MC; Ventura S; Del Monaco V; Ferrari S; Alberghini M; Grilli A; Knuutila S; Schaefer KL; Mattia G; Negrini M; Picci P; Serra M; Scotlandi K
J Pathol; 2012 Apr; 226(5):796-805. PubMed ID: 21960059
[TBL] [Abstract][Full Text] [Related]
37. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells.
Tazawa H; Tsuchiya N; Izumiya M; Nakagama H
Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15472-7. PubMed ID: 17875987
[TBL] [Abstract][Full Text] [Related]
38. Restoration of miR-34a in p53 deficient cells unexpectedly promotes the cell survival by increasing NFκB activity.
Tan J; Fan L; Mao JJ; Chen B; Zheng L; Zhang T; Li T; Duan J; Duan Y; Jin Z; Kuang W
J Cell Biochem; 2012 Sep; 113(9):2903-8. PubMed ID: 22531959
[TBL] [Abstract][Full Text] [Related]
39. miR-34a is downregulated in cis-diamminedichloroplatinum treated sinonasal squamous cell carcinoma patients with poor prognosis.
Ogawa T; Saiki Y; Shiga K; Chen N; Fukushige S; Sunamura M; Nagase H; Hashimoto S; Matsuura K; Saijo S; Kobayashi T; Horii A
Cancer Sci; 2012 Sep; 103(9):1737-43. PubMed ID: 22624980
[TBL] [Abstract][Full Text] [Related]
40. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X
Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
